Clinical Trials Directory

Trials / Completed

CompletedNCT07368790

Elective Total Abdominal Hysterectomy With Preoperative Analgesia Intravenous Paracetamol Versus Placebo

A Comparison of Postoperative Morphine Consumption in Patients Undergoing Elective Total Abdominal Hysterectomy With Preoperative Analgesia Intravenous Paracetamol Versus Placebo

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Queen Savang Vadhana Memorial Hospital, Thailand · Academic / Other
Sex
Female
Age
30 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The study aim to study to evaluate whether IV paracetamol reduces morphine use after TAH. Primary objective was to compare postoperative morphine consumption between the IV paracetamol and control groups. and Secondary objective was to compare postoperative pain scores using the Numeric Rating Scale OR NRS

Detailed description

We conducted a randomized, double-blind, placebo-controlled trial at our hospital (QSMH) , including women undergoing elective TAH The trial was conducted between October 2024 (two thousand twenty-four) and May 2025 (two thousand twenty-five) , with approval from the institutional review board. Participants were randomized 1:1 (one to one) to receive IV paracetamol 1 g or IV normal saline, administered in the operating room before induction of anesthesia, Postoperatively, pain was assessed intermittently using the NRS (์numeric rating scale) at 1, 6, 12, and 24 hours, with morphine 0.1 mg/kg (zero point one milligrams per kilogram) Intravenous provided on demand. The primary outcome was the number of morphine injections within 24 hours; the secondary outcome was NRS pain scores.

Conditions

Interventions

TypeNameDescription
DRUGParacetamolPatients receive IV paracetamol 1 gm Postoperatively morphine 0.1 mg/kg was given intravenous provided on demand at at 1, 6, 12, and 24 hours.
DRUGPlaceboPateint recieved IV normal saline Postoperatively, pain was assessed intermittently using the NRS (์numeric rating scale) at 1, 6, 12, and 24 hours

Timeline

Start date
2024-10-10
Primary completion
2025-05-20
Completion
2025-08-20
First posted
2026-01-27
Last updated
2026-01-27

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT07368790. Inclusion in this directory is not an endorsement.